D-penicillamine, an agent still used in the treatment of rheumatoid ar
thritis (RA) may produce inflammatory myopathy or myositis, Some repor
ted cases are documented with muscle biopsy. We report a 34-year old f
emale, receiving the drug for more than 3 years, who consulted us with
recently developed proximal muscle pain and weakness. EMG-findings we
re typical for inflammatory muscle disease; muscle enzymes remained no
rmal. D-penicillamine was stopped and she was started on prednisolone
with rapid improvement. The EMG-findings, with follow-up within three
months, proved to be a good diagnostic tool, in the absence of laborat
ory muscle enzymes abnormalities.